
News
Filter Results
Displaying 251–260 of 525
-
Dec 14, 2020
End Blindness 2020 Award Winners include Five Foundation-Funded Investigators
Live stream ceremony will include Art Garfunkel, Diane Schuur, and Margaret Atwood. A tribute will also be made to Justice Ruth Bader Ginsburg.
-
Dec 10, 2020
Mr. Ginsberg brings twenty-five years of rare disease corporate development, finance, strategy, and investment leadership experience.
-
Dec 7, 2020
Penn Vet’s William Beltran Elected to the National Academy of Medicine
The veterinary researcher’s canine studies are advancing promising retinal therapies toward clinical trials
-
Dec 3, 2020
Acquisition significantly expands Janssen’s eye disease portfolio and strengthens its gene therapy capabilities. Late-stage AMD affects millions of people with no effective treatments currently available .
-
Nov 19, 2020
Foundation Fighting Blindness Launches ShopFightingBlindness.org
This official store offers branded apparel and merchandise designed to spread awareness and raise funds for the Foundation’s mission.
-
Nov 18, 2020
AGTC Announces Results for Achromatopsia Gene Therapy Clinical Trials
The company will continue enrolling younger patients in higher dosing groups.
-
Nov 9, 2020
Stargazer Pharmaceuticals Initiates a Phase 2a Clinical Trial for its Stargardt Disease Drug
The Foundation Fighting Blindness Retinal Degeneration Fund is an investor in the company
-
Oct 29, 2020
Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
-
-
Oct 21, 2020
SparingVision Raises €44.5 Million for Gene-Independent RP Therapy
The company is planning a clinical trial for its emerging neuroprotective treatment in 2021